PFE logo Pfizer +
Pfizer
+

Pfizer's Revenue (2016 - 2025)

  • Pfizer's annual revenue was $62.58 B in fiscal year 2025. The annual revenue decreased -$1.05 B from $63.63 B (in 2024) to $62.58 B (in 2025), representing a -1.65% year-over-year decline.

  • Pfizer's quarterly revenue was $14.45 B in the quarter ending Mar 2026. The quarterly revenue increased $736.00 M from $13.72 B (in Q1: Dec 2025) to $14.45 B (in Q1: Dec 2026), representing a 5.37% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
  • The highest annual revenue for Pfizer was $100.33 B in fiscal year 2022.
  • The lowest annual revenue was $41.17 B in fiscal year 2019.
  • The average revenue was $60.92 B.

    • Learn more about Pfizer's Revenue by Segment and Revenue by Region.

    Check out competitors to Pfizer in a side-by-side comparison.

    Explore additional financial metrics for Pfizer.


    Definition of Revenue :
  • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Continue reading...

Pfizer's Revenue Trend

2025

Pfizer's annual revenue was $62.58 B in fiscal year 2025.

Pfizer's quarterly revenue was $13.72 B(Q1: Mar 2025), $14.65 B(Q2: Jun 2025), $16.65 B(Q3: Sep 2025), $17.56 B(Q4: Dec 2025) in fiscal year 2025.

2024

Pfizer's annual revenue was $63.63 B in fiscal year 2024.

Pfizer's quarterly revenue was $14.88 B(Q1: Mar 2024), $13.28 B(Q2: Jun 2024), $17.70 B(Q3: Sep 2024), $17.76 B(Q4: Dec 2024) in fiscal year 2024.

2023

Pfizer's annual revenue was $59.55 B in fiscal year 2023.

Pfizer's quarterly revenue was $18.49 B(Q1: Apr 2023), $13.01 B(Q2: Jul 2023), $13.49 B(Q3: Oct 2023), $14.57 B(Q4: Dec 2023) in fiscal year 2023.

2022

Pfizer's annual revenue was $100.33 B in fiscal year 2022.

Pfizer's quarterly revenue was $25.66 B(Q1: Apr 2022), $27.74 B(Q2: Jul 2022), $22.64 B(Q3: Oct 2022), $24.29 B(Q4: Dec 2022) in fiscal year 2022.

2021

Pfizer's annual revenue was $81.29 B in fiscal year 2021.

Pfizer's quarterly revenue was $14.52 B(Q1: Apr 2021), $18.90 B(Q2: Jul 2021), $24.04 B(Q3: Oct 2021), $23.84 B(Q4: Dec 2021) in fiscal year 2021.

2020

Pfizer's annual revenue was $41.65 B in fiscal year 2020.

Pfizer's quarterly revenue was $10.08 B(Q1: Mar 2020), $9.86 B(Q2: Jun 2020), $10.28 B(Q3: Sep 2020), $11.63 B(Q4: Dec 2020) in fiscal year 2020.

2019

Pfizer's annual revenue was $41.17 B in fiscal year 2019.

Pfizer's quarterly revenue was $13.12 B(Q1: Mar 2019), $13.26 B(Q2: Jun 2019), $12.68 B(Q3: Sep 2019), $12.69 B(Q4: Dec 2019) in fiscal year 2019.

2018

Pfizer's annual revenue was $53.65 B in fiscal year 2018.

Pfizer's quarterly revenue was $12.91 B(Q1: Apr 2018), $13.47 B(Q2: Jul 2018), $13.30 B(Q3: Sep 2018), $13.98 B(Q4: Dec 2018) in fiscal year 2018.

2017

Pfizer's annual revenue was $52.55 B in fiscal year 2017.

Pfizer's quarterly revenue was $12.78 B(Q1: Apr 2017), $12.90 B(Q2: Jul 2017), $13.17 B(Q3: Oct 2017), $13.70 B(Q4: Dec 2017) in fiscal year 2017.

2016

Pfizer's annual revenue was $52.82 B in fiscal year 2016.

Pfizer's quarterly revenue was $13.01 B(Q1: Apr 2016), $13.15 B(Q2: Jul 2016), $13.05 B(Q3: Oct 2016), $13.63 B(Q4: Dec 2016) in fiscal year 2016.

Continue reading...

Pfizer's Revenue (Year-over-Year Change)

2015 0
2016 +8.13
2017 -0.53
2018 +2.10
2019 -23.25
2020 +1.16
2021 +95.16
2022 +23.43
2023 -40.64
2024 +6.84
2025 -1.65

2025

Pfizer’s annual revenue decreased -1.65% during fiscal year 2025 compared to 2024. It represents a decline of $1.05 B from $63.63 B (in 2024) to $62.58 B (in 2025).

2024

Pfizer’s annual revenue increased +6.84% during fiscal year 2024 compared to 2023. It represents a growth of $4.07 B from $59.55 B (in 2023) to $63.63 B (in 2024).

2023

Pfizer’s annual revenue decreased -40.64% during fiscal year 2023 compared to 2022. It represents a decline of $40.78 B from $100.33 B (in 2022) to $59.55 B (in 2023).

2022

Pfizer’s annual revenue increased +23.43% during fiscal year 2022 compared to 2021. It represents a growth of $19.04 B from $81.29 B (in 2021) to $100.33 B (in 2022).

2021

Pfizer’s annual revenue increased +95.16% during fiscal year 2021 compared to 2020. It represents a growth of $39.64 B from $41.65 B (in 2020) to $81.29 B (in 2021).

2020

Pfizer’s annual revenue increased +1.16% during fiscal year 2020 compared to 2019. It represents a growth of $479.00 M from $41.17 B (in 2019) to $41.65 B (in 2020).

2019

Pfizer’s annual revenue decreased -23.25% during fiscal year 2019 compared to 2018. It represents a decline of $12.48 B from $53.65 B (in 2018) to $41.17 B (in 2019).

2018

Pfizer’s annual revenue increased +2.10% during fiscal year 2018 compared to 2017. It represents a growth of $1.10 B from $52.55 B (in 2017) to $53.65 B (in 2018).

2017

Pfizer’s annual revenue decreased -0.53% during fiscal year 2017 compared to 2016. It represents a decline of $278.00 M from $52.82 B (in 2016) to $52.55 B (in 2017).

2016

Pfizer’s annual revenue increased +8.13% during fiscal year 2016 compared to 2015. It represents a growth of $3.97 B from $48.85 B (in 2015) to $52.82 B (in 2016).

Continue reading...

Pfizer Revenue History

Sign in to download table

Period Revenue Year-over-Year Change
FY 2025
$62.58 B -$1.05 B 1.65%
Q4: Dec 25 $17.56 B -$206.00 M 1.16%
Q3: Sep 25 $16.65 B -$1.05 B 5.92%
Q2: Jun 25 $14.65 B $1.37 B 10.31%
Q1: Mar 25 $13.72 B -$1.16 B 7.82%
FY 2024
$63.63 B $4.07 B 6.84%
Q4: Dec 24 $17.76 B $3.19 B 21.91%
Q3: Sep 24 $17.70 B $4.21 B 31.21%
Q2: Jun 24 $13.28 B $276.00 M 2.12%
Q1: Mar 24 $14.88 B -$3.61 B 19.51%
FY 2023
$59.55 B -$40.78 B 40.64%
Q4: Dec 23 $14.57 B -$9.72 B 40.02%
Q3: Oct 23 $13.49 B -$9.15 B 40.41%
Q2: Jul 23 $13.01 B -$14.74 B 53.11%
Q1: Apr 23 $18.49 B -$7.18 B 27.96%
FY 2022
$100.33 B $19.04 B 23.43%
Q4: Dec 22 $24.29 B $452.00 M 1.9%
Q3: Oct 22 $22.64 B -$1.40 B 5.81%
Q2: Jul 22 $27.74 B $8.84 B 46.79%
Q1: Apr 22 $25.66 B $11.15 B 76.78%
FY 2021
$81.29 B $39.64 B 95.16%
Q4: Dec 21 $23.84 B $12.20 B 104.9%
Q3: Oct 21 $24.04 B $13.76 B 133.87%
Q2: Jul 21 $18.90 B $9.04 B 91.6%
Q1: Apr 21 $14.52 B $4.43 B 43.97%
FY 2020
$41.65 B $479.00 M 1.16%
Q4: Dec 20 $11.63 B -$1.05 B 8.31%
Q3: Sep 20 $10.28 B -$2.40 B 18.95%
Q2: Jun 20 $9.86 B -$3.40 B 25.63%
Q1: Mar 20 $10.08 B -$3.04 B 23.14%
FY 2019
$41.17 B -$12.48 B 23.25%
Q4: Dec 19 $12.69 B -$1.29 B 9.22%
Q3: Sep 19 $12.68 B -$618.00 M 4.65%
Q2: Jun 19 $13.26 B -$202.00 M 1.5%
Q1: Mar 19 $13.12 B $212.00 M 1.64%
FY 2018
$53.65 B $1.10 B 2.1%
Q4: Dec 18 $13.98 B $273.00 M 1.99%
Q3: Sep 18 $13.30 B $130.00 M 0.99%
Q2: Jul 18 $13.47 B $570.00 M 4.42%
Q1: Apr 18 $12.91 B $127.00 M 0.99%
FY 2017
$52.55 B -$278.00 M 0.53%
Q4: Dec 17 $13.70 B $76.00 M 0.56%
Q3: Oct 17 $13.17 B $123.00 M 0.94%
Q2: Jul 17 $12.90 B -$251.00 M 1.91%
Q1: Apr 17 $12.78 B -$226.00 M 1.74%
FY 2016
$52.82 B $3.97 B 8.13%
Q4: Dec 16 $13.63 B -$420.00 M 2.99%
Q3: Oct 16 $13.05 B $958.00 M 7.93%
Q2: Jul 16 $13.15 B $1.29 B 10.92%
Q1: Apr 16 $13.01 B $2.14 B 19.71%

Frequently Asked Questions

What is the annual revenue of Pfizer?

In fiscal year 2025, Pfizer's revenue was $62.58 Billion.

How much did Pfizer's revenue change in the last year?

Pfizer's revenue decreased by -1.65% (-$1.05 Billion) in 2025 compared to 2024.

What is Pfizer's most recent quarterly revenue?

In the first quarter (Q1) of 2026, Pfizer reported a revenue of $14.45 Billion.

What is Pfizer's revenue per share (TTM)?

Pfizer's revenue per share over the trailing twelve months is $11.13.

What is Pfizer's revenue per employee?

In the fiscal year 2025, Pfizer's revenue per employee was $834.39 K.

What is the annual net income of Pfizer?

In fiscal year 2025, Pfizer's net income was $7.77 Billion.

What is Pfizer's biggest product segment, and what is its revenue?

Biopharma Segment is Pfizer's biggest product segment, generating $61.20 Billion in revenue for fiscal year 2025.

What is Pfizer's net income per employee?

In the fiscal year 2025, Pfizer's net income per employee was $103.60 K.

Related

People Also Search For

Submit feedback to Bullfincher